Pivotal role in high quality investment deals in GenesisCare and Genscript.
Top pedigree investments, IPOs and trade sales over 19 years with Andera Partners.
Grew small biotech start-up with upside to 150-person, publicly-traded company with approved, marketed product.
Founded and led Arrow Therapeutics Ltd to $150 million acquisition by AstraZeneca.
Highest quality investments including successful public listings of Orphazyme (ORPHA) and ObsEva (OBSV).